Analysis and Perspectives

Jan 25, 2023

The global Aesthetic Implants Market to grow at a CAGR of 7.82% by 2027. Several clinical, commercial, and regulatory developments are stimulating the market growth

Jan 23, 2023

The uncomplicated UTI treatment market is expected to reach ~USD 3.5 billion in 7MM by 2032, with expected approvals of emerging therapies.

Jan 20, 2023

PTSD treatment market lacks effective treatment options. Therefore, new therapies will have more opportunities and less market competition.

Jan 18, 2023

The global Drug Delivery Devices Market is expected to grow at a CAGR of 7.90% by 2027. Advances in the device's development are driving the market growth

Jan 16, 2023

The upcoming acute ocular pain treatment therapies contain advantageous technologies that address shortcomings in therapeutics segment.

Jan 13, 2023

Currently, off-label therapies sit at top of Behcet’s syndrome treatment market. However, there is unmet need for approved therapies

Jan 11, 2023

The global Digital Health market is estimated to grow at a CAGR of 18.25% during the forecast period (2022 to 2027) and is anticipated to reach USD 486.55 billion by 2027. Over the past few years, several transformative trends and developments have been registered in the Digital Health market landscape.

Jan 09, 2023

The emerging eosinophilic esophagitis treatment market shows potential with a couple of mAbs waiting in line for their approval in EoE space.

Oct 31, 2022

The clinical diagnostics market is highly competitive, with the active participation of numerous MedTech giants and regional players. Over the past few years, several key commercial and regulatory developments have immensely propelled the Clinical Diagnostics Market growth. However, there are a few challenges in the segment that are hampering the market growth

Oct 24, 2022

In 2021, the around 53 million people in the US were affected by chronic pain. To overcome the therapeutic challenges, there are several pharmacological options for chronic pain treatment. Non-opioid analgesics, including NSAIDs, acetaminophen, and aspirin, are available in the market for better outcomes.